Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Other Operating Expenses (2024 - 2026)

NeuroPace has reported Other Operating Expenses over the past 3 years, most recently at $11.6 million for Q1 2026.

  • For Q1 2026, Other Operating Expenses rose 5.27% year-over-year to $11.6 million; the TTM value through Mar 2026 reached $47.2 million, up 16.05%, while the annual FY2025 figure was $46.6 million, 17.42% up from the prior year.
  • Other Operating Expenses for Q1 2026 was $11.6 million at NeuroPace, up from $10.9 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $12.6 million in Q3 2025 and troughed at $9.8 million in Q2 2024.
  • A 3-year average of $11.0 million and a median of $11.0 million in 2025 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: grew 26.88% in 2025 and later grew 5.27% in 2026.
  • Year by year, Other Operating Expenses stood at $10.0 million in 2024, then rose by 9.9% to $10.9 million in 2025, then grew by 5.92% to $11.6 million in 2026.
  • Business Quant data shows Other Operating Expenses for NPCE at $11.6 million in Q1 2026, $10.9 million in Q4 2025, and $12.6 million in Q3 2025.